6-Desacetyl-6-Bromo Palbociclib

An impurity of Palbociclib, a selective inhibitor of cyclin-dependent kinases CDK4 and CDK6. Palbociclib is developed for the treatment of ER-positive and HER2-negative breast cancer.
Supplier BOC Sciences
Product # B1476-283285
Pricing Inquire
Cas 851067-56-6
Molecular Weight 484.402
Molecular Formula C22H26BrN7O
Canonical SMILES CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)Br
Feedback